Understanding Superficial Spreading Melanoma: Diagnosis and Treatment Guide

Superficial spreading melanoma (SSM) is the most common form of melanoma, accounting for approximately 70% of all cases. It typically originates in the melanocytes, the cells responsible for skin pigment, and begins by growing horizontally across the top layer of the skin, a phase known as radial growth.

While SSM can appear anywhere on the body, it is most frequently found on the backs of men and the legs of women. It often presents as a flat or slightly raised discolored patch with irregular borders and varied colors, including shades of black, brown, tan and sometimes pink or red. Because it grows slowly on the surface before penetrating deeper into the skin, early detection is critical for a favorable prognosis.

Diagnosis

The diagnostic process begins with a clinical skin examination. Oncologists and dermatologists often use the ABCDE rule to identify suspicious lesions:

• Asymmetry: One half of the spot does not match the other.
• Border: The edges are irregular, ragged or blurred.
• Color: The color is not uniform and may include different shades.
• Diameter: The spot is larger than 6 millimeters (about the size of a pencil eraser).
• Evolving: The mole is changing in size, shape or color.

If a lesion is suspected to be SSM, a skin biopsy is performed. A pathologist examines the tissue sample to determine the Breslow thickness, which measures how deep the tumor has grown in millimeters. This measurement is the most significant factor in predicting the risk of the cancer spreading. If the melanoma is deeper than 0.8 millimeters, a sentinel lymph node biopsy may be recommended to check if the cancer has reached the lymphatic system.

Treatment options

Treatment for SSM is highly personalized based on the stage of the cancer at diagnosis.

Surgical Intervention

The primary treatment for localized SSM is wide local excision. A surgeon removes the melanoma along with a margin of healthy surrounding skin to ensure no cancer cells remain.

Targeted therapy

For patients whose melanoma contains specific genetic mutations, such as the BRAF mutation, targeted drugs may be used. These medications work by blocking the specific proteins that allow the cancer cells to grow and divide.

Immunotherapy

Immunotherapy has revolutionized melanoma care. These treatments help the patient’s own immune system recognize and attack cancer cells. Common options include checkpoint inhibitors, which "unmask" cancer cells that are trying to hide from the immune system.

Radiation and chemotherapy

While less common for SSM than surgery or immunotherapy, radiation may be used if the cancer has spread to the brain or bones, or to shrink a tumor before surgery.

Side effects

Patients should prepare for potential side effects, which vary depending on the chosen treatment path.

• Surgical Effects: Common issues include localized pain, scarring and a risk of infection at the incision site. If lymph nodes are removed, some patients may experience lymphedema, or swelling in the limbs.
• Immunotherapy Side Effects: Because these drugs ramp up the immune system, they can cause inflammation in healthy organs. This may manifest as skin rashes, fatigue, diarrhea, or more serious issues like colitis or pneumonitis.
• Targeted Therapy Effects: Patients may experience fever, chills, joint pain and sensitivity to sunlight.

Conclusion

A diagnosis of superficial spreading melanoma can be overwhelming, but it is a highly treatable disease when caught early. Advances in precision medicine and immunotherapy have significantly improved survival rates even for more advanced stages.

Patients are encouraged to use this overview as a foundation for a dialogue with their healthcare team. Asking about the Breslow thickness of the tumor, the presence of genetic mutations and the specific goals of a proposed treatment plan will help ensure a collaborative approach to care. Regular skin checks and sun protection remain the most effective tools for long-term health and monitoring for recurrence.

Editor's note: This article is for informational purposes only and is not a substitute for professional medical advice, as your own experience will be unique. Use this article to guide discussions with your oncologist. Content was generated with AI, reviewed by a human editor, but not independently verified by a medical professional.

For more news on cancer updates, research and education, don’t forget to subscribe to CURE®’s newsletters here.